Retrospective Multicenter Real-Life Study on the First-Line Treatment of Classical Hodgkin Lymphoma in Argentina

There are no data in Argentina on the response rates to first-line treatment of classical Hodgkin Lymphoma (cHL) outside clinical trials. A total of 498 patients from 7 public and private hospitals in Argentina were retrospectively examined. The median follow-up was 37.4 months (CI 95% 17.7–63.5). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahuad, Carolina, Victoria, Otero, Laura, Korin, Enriqueta, Martinez, Fernando, Warley, Hernán, García Rivello, Nancy, Cristaldo, Dana, Kohan, Marta, Zerga, Gonzalo, Garate, de los Ángeles, Vicente Repáraz María, Florencia, Aizpurua, Erica, Rojas Bilbao, Susana, Cerana, Eugenia, Funes Maria, Iliana, Plaza, Cecilia, Foncuberta, Anahí, Vijnovich Baron, Santiago, Cranco, Adriana, Vitriu, Mariela, Gomez, Justina, Lavalle, Claudia, Casali, Manuela, Clavijo, Luciana, Melillo, Cecilia, Cabral Lorenzo Maria, Augusto, Miroli, Laura, Fischman, Maximiliano, Pavlove, Marcela, Miodosky, Silvana, Cugliari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358792/
https://www.ncbi.nlm.nih.gov/pubmed/35950206
http://dx.doi.org/10.1007/s44228-022-00008-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358792/
https://www.ncbi.nlm.nih.gov/pubmed/35950206
http://dx.doi.org/10.1007/s44228-022-00008-4

Ejemplares similares